Group items tagged

Clinical Trial Authorization (CTA) is mandatory to conduct clinical trials in humans. CTA can only be obtained after submission of a group of scientific documents in the form of Investigational Medicinal Product Dossier (IMPD).

Dr. Somashekhar S. P is happy to offer one of the world's greatest and most broad projects in advanced mechanics malignant growth method.

Dr. Somashekhar SP is renowned for his vast experience and expert is in advanced integrative medicines, which has helped many cancer patients around the world.

Developing a new medicine is a sophisticated and complex task which initially begins with the understanding of disease or condition as thoroughly as possible. At first, the researchers conduct studies in cells, tissues and animal models to determine whether the disease or condition can be influenced by new molecule.

Germany-based OctreoPharm Sciences has received Orphan Drug Designation from the European Medicines Agency (EMA) for OPS202 as a diagnostic agent for the management of patients with gastro-entero-pancreatic-neuroendocrine tumors

Immuneering has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb (BMS) for the use of Immuneering's proprietary computational biology methods to identify biological insights that would help in the discovery and development of medicines.

Leading and reliable source of health news updates round the clock every day with RSS feeds

Patients with an inherited kidney disease may be helped by a drug that is currently available for other uses, scientists at UC Santa Barbara have discovered.